Skip to content

Radioimmunotherapy clears HIV-infected cells in mice

Brazil begins negotiations over Kaletra price again

Antenatal cotrimoxazole prophylaxis leads to cost-effective reduction in preterm delivery and neonatal mortality, Zambian study reveals

Second generic abacavir approved for PEPFAR

New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis

Extensively drug-resistant TB (XDR-TB) present throughout the world

Leading activist chides TB world for complacency in the face of MDR and now XDR-TB

Lowering the threshold — Is there a case for re-evaluating eligibility criteria for ART?

Australian prosecutions for HIV transmission highlight need for current UK consultations, deadlines approach